Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avlar BioVentures Ltd.

This article was originally published in Start Up

Executive Summary

The UK's Avlar BioVentures is not concerned about the overshadowing popularity of Internet stocks or the present volatility of biotech stocks. It has amassed a pool of patient capital for European biotech start-ups. Avlar BioVenture's new seed fund is just completing a second closing that will bring the total raised to 20 million pounds sterling.

Topics

Related Deals

UsernamePublicRestriction

Register

SC090141

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel